202 related articles for article (PubMed ID: 14671102)
1. Subsets of memory cytotoxic T lymphocytes elicited by vaccination influence the efficiency of secondary expansion in vivo.
Seaman MS; Peyerl FW; Jackson SS; Lifton MA; Gorgone DA; Schmitz JE; Letvin NL
J Virol; 2004 Jan; 78(1):206-15. PubMed ID: 14671102
[TBL] [Abstract][Full Text] [Related]
2. Functional equivalency of B7-1 and B7-2 for costimulating plasmid DNA vaccine-elicited CTL responses.
Santra S; Barouch DH; Jackson SS; Kuroda MJ; Schmitz JE; Lifton MA; Sharpe AH; Letvin NL
J Immunol; 2000 Dec; 165(12):6791-5. PubMed ID: 11120800
[TBL] [Abstract][Full Text] [Related]
3. Potent CD4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF.
Barouch DH; Santra S; Tenner-Racz K; Racz P; Kuroda MJ; Schmitz JE; Jackson SS; Lifton MA; Freed DC; Perry HC; Davies ME; Shiver JW; Letvin NL
J Immunol; 2002 Jan; 168(2):562-8. PubMed ID: 11777947
[TBL] [Abstract][Full Text] [Related]
4. Induction of potent CD8+ T-cell responses by novel biodegradable nanoparticles carrying human immunodeficiency virus type 1 gp120.
Wang X; Uto T; Akagi T; Akashi M; Baba M
J Virol; 2007 Sep; 81(18):10009-16. PubMed ID: 17609261
[TBL] [Abstract][Full Text] [Related]
5. Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration.
Barouch DH; Santra S; Steenbeke TD; Zheng XX; Perry HC; Davies ME; Freed DC; Craiu A; Strom TB; Shiver JW; Letvin NL
J Immunol; 1998 Aug; 161(4):1875-82. PubMed ID: 9712056
[TBL] [Abstract][Full Text] [Related]
6. Anti-HIV env immunities elicited by nucleic acid vaccines.
Shiver JW; Davies ME; Yasutomi Y; Perry HC; Freed DC; Letvin NL; Liu MA
Vaccine; 1997 Jun; 15(8):884-7. PubMed ID: 9234539
[TBL] [Abstract][Full Text] [Related]
7. Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex.
Garzón MR; Berraondo P; Crettaz J; Ochoa L; Vera M; Lasarte JJ; Vales A; Van Rooijen N; Ruiz J; Prieto J; Zulueta J; González-Aseguinolaza G
Vaccine; 2005 Feb; 23(11):1384-92. PubMed ID: 15661387
[TBL] [Abstract][Full Text] [Related]
8. Topical application of HIV DNA vaccine with cytokine-expression plasmids induces strong antigen-specific immune responses.
Liu LJ; Watabe S; Yang J; Hamajima K; Ishii N; Hagiwara E; Onari K; Xin KQ; Okuda K
Vaccine; 2001 Oct; 20(1-2):42-8. PubMed ID: 11567744
[TBL] [Abstract][Full Text] [Related]
9. Rapid memory CD8+ T-lymphocyte induction through priming with recombinant Mycobacterium smegmatis.
Hovav AH; Cayabyab MJ; Panas MW; Santra S; Greenland J; Geiben R; Haynes BF; Jacobs WR; Letvin NL
J Virol; 2007 Jan; 81(1):74-83. PubMed ID: 17050608
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit.
Barnett SW; Rajasekar S; Legg H; Doe B; Fuller DH; Haynes JR; Walker CM; Steimer KS
Vaccine; 1997 Jun; 15(8):869-73. PubMed ID: 9234536
[TBL] [Abstract][Full Text] [Related]
11. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
[TBL] [Abstract][Full Text] [Related]
12. A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine.
Fuller DH; Haynes JR
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1433-41. PubMed ID: 7888198
[TBL] [Abstract][Full Text] [Related]
13. Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice.
Nanjundappa RH; Wang R; Xie Y; Umeshappa CS; Xiang J
Vaccine; 2012 May; 30(24):3519-25. PubMed ID: 22484292
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of gp120-specific immune responses by genetic vaccination with the human immunodeficiency virus type 1 envelope gene fused to the gene coding for soluble CTLA4.
Nayak BP; Sailaja G; Jabbar AM
J Virol; 2003 Oct; 77(20):10850-61. PubMed ID: 14512535
[TBL] [Abstract][Full Text] [Related]
15. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
Gómez CE; Abaitua F; Rodríguez D; Esteban M
Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
[TBL] [Abstract][Full Text] [Related]
16. HIV type 1 vaccine-induced T cell memory and cytotoxic T lymphocyte responses in HIV type 1-uninfected volunteers.
Gorse GJ; Patel GB; Belshe RB;
AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1175-89. PubMed ID: 11522187
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with a Shigella DNA vaccine vector induces antigen-specific CD8(+) T cells and antiviral protective immunity.
Shata MT; Hone DM
J Virol; 2001 Oct; 75(20):9665-70. PubMed ID: 11559798
[TBL] [Abstract][Full Text] [Related]
18. Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine. NIAID AIDS Vaccine Evaluation Group.
Sabbaj S; Mulligan MJ; Hsieh RH; Belshe RB; McGhee JR
AIDS; 2000 Jul; 14(10):1365-74. PubMed ID: 10930151
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-12 is necessary for the priming of CD4+ T cells required during the elicitation of HIV-1 gp120-specific cytotoxic T-lymphocyte function.
Gupta S; Boppana R; Mishra GC; Saha B; Mitra D
Immunology; 2008 Aug; 124(4):553-61. PubMed ID: 18298551
[TBL] [Abstract][Full Text] [Related]
20. Ag85B of mycobacteria elicits effective CTL responses through activation of robust Th1 immunity as a novel adjuvant in DNA vaccine.
Takamura S; Matsuo K; Takebe Y; Yasutomi Y
J Immunol; 2005 Aug; 175(4):2541-7. PubMed ID: 16081827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]